Revelation Biosciences Q3 EPS $(5.92) Beats $(6.16) Estimate
Benzinga Newsdesk 30 minutes ago
NewsEarningsEarnings Beats
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(5.92) per share which beat the analyst consensus estimate of $(6.16) by 3.9 percent. This is a 88.04 percent increase over losses of $(49.51) per share
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(5.92) per share which beat the analyst consensus estimate of $(6.16) by 3.9 percent. This is a 88.04 percent increase over losses of $(49.51) per share from the same period last year.